Mesa Laboratories Inc
NASDAQ:MLAB
Mesa Laboratories Inc
NASDAQ:MLAB
Price:
95.7 USD
-13.41%
Market Closed
Updated:
Jun 3, 2024
Mesa Laboratories Inc
Other Current Liabilities
|
Mesa Laboratories Inc
Other Current Liabilities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mesa Laboratories Inc
NASDAQ:MLAB
|
Other Current Liabilities
$16.2m
|
CAGR 3-Years
29%
|
CAGR 5-Years
18%
|
CAGR 10-Years
18%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Current Liabilities
$956m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
12%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Current Liabilities
$749m
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Current Liabilities
$1.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
3%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Current Liabilities
$489.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
See Also
What is Mesa Laboratories Inc's Other Current Liabilities?
Other Current Liabilities
16.2m
USD
16.2m
USD
Based on the financial report for Dec 31, 2023, Mesa Laboratories Inc's Other Current Liabilities amounts to 16.2m USD.
What is Mesa Laboratories Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
18%
18%
Over the last year, the Other Current Liabilities growth was 11%. The average annual Other Current Liabilities growth rates for Mesa Laboratories Inc have been 29% over the past three years , 18% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
